Today's Information |
Provided by: TaiMed Biologics Inc. | |||||
SEQ_NO | 2 | Date of announcement | 2022/05/30 | Time of announcement | 15:50:56 |
Subject | Announcement of members of the Company's 3rd Audit Committee | ||||
Date of events | 2022/05/30 | To which item it meets | paragraph 6 | ||
Statement | 1.Date of occurrence of the change: 2022/05/30 2.Name of the functional committees: Audit Committee 3.Name of the previous position holder: (1) Ming-Ching Chen (2) Howard S. Lee (3) Gwo-Fong Lin 4.Resume of the previous position holder: (1) Ming-Ching Chen/Professorof of Accounting, National ChengChi University (2) Howard S. Lee/Chairman of TAHO Pharmceuticals and Transwell Biotech Co. (3) Gwo-Fong Lin/Distinguished Professor, National Taiwan University 5.Name of the new position holder: (1) Chin-Ting, Chiu (2) Howard S. Lee (3) Gwo-Fong Lin 6.Resume of the new position holder: (1) Chin-Ting, Chiu/former chairman, Securities and Futures Investors Protection Center (2) Howard S. Lee/Chairman of TAHO Pharmceuticals and Transwell Biotech Co. (3) Gwo-Fong Lin/Distinguished Professor, National Taiwan University 7.Circumstances of change (Please enter "resignation", "dismissal", "term expired", "death" or "new appointment"):term expired 8.Reason for the change:term expired and re-election 9.Original term (from __________ to __________):2019/06/06 to 2022/06/05 10.Effective date of the new member:2022/05/30 11.Any other matters that need to be specified:None |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
TaiMed Biologics Inc. published this content on 30 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 May 2022 14:38:07 UTC.